Sven Hoffner Selected Research

Therapeutics

12/2017	A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.
1/2016	Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China.
6/2009	High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sven Hoffner Research Topics

Disease

34	Tuberculosis (Tuberculoses) 01/2022 - 06/2002
15	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021 - 05/2008
8	Extensively Drug-Resistant Tuberculosis 07/2020 - 02/2008
4	Infections 01/2022 - 01/2011
4	Multiple Organ Failure (MODS) 10/2013 - 05/2009
3	Pulmonary Tuberculosis 11/2021 - 06/2009
2	Reinfection 12/2021 - 07/2021
2	HIV Infections (HIV Infection) 01/2007 - 05/2002
1	Coinfection 12/2021
1	Genomic Instability 01/2011
1	Infection with Mycobacterium marinum 01/2011
1	Persistent Infection 01/2011

Drug/Important Bio-Agent (IBA)

38	Pharmaceutical PreparationsIBA 12/2021 - 05/2002
10	Isoniazid (Ftivazide)FDA LinkGeneric 01/2018 - 06/2002
9	Rifampin (Rifampicin)FDA LinkGeneric 01/2018 - 01/2005
7	FluoroquinolonesIBA 06/2020 - 08/2013
6	Pyrazinamide FDA LinkGeneric 12/2021 - 01/2005
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2011
3	Moxifloxacin (Avelox)FDA Link 01/2021 - 01/2014
3	Nitrate ReductaseIBA 09/2013 - 05/2009
2	Antitubercular AgentsIBA 04/2017 - 12/2016
2	bedaquiline (R207910)IBA 12/2016 - 01/2005
2	EnzymesIBA 01/2014 - 01/2011
2	Indicators and Reagents (Reagents)IBA 09/2013 - 02/2008
1	Levofloxacin (Levaquin)FDA Link 01/2021
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2018
1	DiarylquinolinesIBA 12/2016
1	AgarIBA 12/2016
1	ebselenIBA 06/2016
1	DNA GyraseIBA 01/2014
1	Adenosine Triphosphatases (ATPase)IBA 01/2014
1	Mycolic Acids (Mycolic Acid)IBA 04/2012
1	arabinogalactanIBA 04/2012
1	ethyl 4-methoxycinnamateIBA 07/2011
1	EicosanoidsIBA 01/2011
1	leukotriene A4 hydrolaseIBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 12/2010
1	resazurinIBA 10/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009
1	natural resistance-associated macrophage protein 1IBA 08/2009
1	Calcitriol Receptors (Calcitriol Receptor)IBA 08/2009
1	malachite greenIBA 02/2008
1	Coloring Agents (Dyes)IBA 02/2008
1	Antimicrobial PeptidesIBA 07/2006
1	streptolysin OIBA 07/2006
1	Proteins (Proteins, Gene)FDA Link 07/2006

Therapy/Procedure

4	Injections 12/2016 - 08/2013
3	Therapeutics 12/2017 - 06/2009